Multimedialna platforma wiedzy medycznej Internetowa Księgarnia Medyczna Kalendarium Konferencji
Folia Histochemica et Cytobiologica
MENU
Shortcuts Submit an article Author Guidelines Ahead of Print Reviewers 2023 Editorial Board

open access

Vol 60, No 1 (2022)
Original paper
Submitted: 2021-07-17
Accepted: 2022-01-27
Published online: 2022-02-14
View PDF Download PDF file
Get Citation

Insulin-like growth factor-1 inhibits apoptosis of rat gastric smooth muscle cells under high glucose condition via adenosine monophosphate-activated protein kinase (AMPK) pathway

Xiang-zi Zhang12, Yan Sun1, Mo-han Zhang1, Zheng Jin1
DOI: 10.5603/FHC.a2022.0005
·
Pubmed: 35156189
·
Folia Histochem Cytobiol 2022;60(1):74-88.
Affiliations
  1. Yanbian University College of Medicine, Yanji 133000, China
  2. Department of Stomatology, Affiliated Hospital of Yanbian University,Yanji 133000, China

open access

Vol 60, No 1 (2022)
ORIGINAL PAPERS
Submitted: 2021-07-17
Accepted: 2022-01-27
Published online: 2022-02-14

Abstract

Introduction. Diabetic gastroparesis (DGP) is a common chronic complication of diabetes characterized by decreased gastric motility, and an effective number of gastric smooth muscle cells (GSMCs) ensures gastric motility. A previous study documented that apoptosis was present in gastric smooth muscles in rats with DGP and adenosine monophosphate-activated protein kinase (AMPK) was an important factor of apoptosis of rat GSMCs cultured under high glucose conditions. This study aimed to explore the effect of insulin-like growth factor-1 (IGF-1) on apoptosis of high glucose cultured rat GSMCs after silencing of AMPK and elucidate the underlying mechanism.

Material and methods. A total of 120 rats were divided into normal control (NC, n = 20), diabetic gastroparesis (DGP, n = 50) and DGP + IGF-1 (n = 50) groups. After establishing the rat model of DGP, rats in the DGP+IGF-1 group received an intraperitoneal injection of IGF-1 at a dose of 1.5 μg/kg/d for 10 weeks. The level of AMPK activity, liver kinase B1 (LKB1) activity, and calcium/calmodulin-dependent protein kinase b (CaMKKb) expression in rat gastric smooth muscle tissues was detected by Western blot analysis. Apoptosis in rat gastric smooth muscle tissues was detected by TUNEL assay. We also cultured rat GSMCs in vitro under high glucose (HG) condition (35 mM), incubated cells with IGF-1, and silenced AMPK with siRNA. The cells were divided into HG, HG + IGF-1, HG + siRNA, and HG + siRNA + IGF-1 groups. The apoptosis rates of rat GSMCs after silencing AMPK were detected by TUNEL assay and flow cytometry, and apoptosis-related protein expression in rat GSMCs was detected by Western blot.

Results. IGF-1 decreased LKB1 activity, CaMKKb expression, AMPK activity, and inhibited apoptosis in rat gastric smooth muscle tissues. Compared with rat GSMCs cultured in vitro under HG conditions, apoptosis rates were reduced after treatment with IGF-1 and AMPK silencing (both p < 0.01). Apoptosis rates were higher in the HG + siRNA group compared with the HG + IGF-1 group (p < 0.05). IGF-1 down-regulated the expression of calcium/calmodulin-dependent kinase II (CaMKII) and p53, up-regulated the expression of p21, PLC-b3, PI3K p110 Ser1070, and the activities of Akt, p70S6K, mTORC1, and mTORC2. IGF-1 also up-regulated Bcl-2 expression and down-regulated the expression of BAX and Caspase-3.

Conclusions. IGF-1 can inhibit the apoptosis of rat GSMCs under high glucose conditions, its mechanism may be related to the regulation of expression and activity of p53, PI3K, TSC-2, Akt, mTOR, 4E-BP1, p70S6K, p21, CaMKII, and PLC-b3 in rat GSMCs acting through AMPK pathway.

Abstract

Introduction. Diabetic gastroparesis (DGP) is a common chronic complication of diabetes characterized by decreased gastric motility, and an effective number of gastric smooth muscle cells (GSMCs) ensures gastric motility. A previous study documented that apoptosis was present in gastric smooth muscles in rats with DGP and adenosine monophosphate-activated protein kinase (AMPK) was an important factor of apoptosis of rat GSMCs cultured under high glucose conditions. This study aimed to explore the effect of insulin-like growth factor-1 (IGF-1) on apoptosis of high glucose cultured rat GSMCs after silencing of AMPK and elucidate the underlying mechanism.

Material and methods. A total of 120 rats were divided into normal control (NC, n = 20), diabetic gastroparesis (DGP, n = 50) and DGP + IGF-1 (n = 50) groups. After establishing the rat model of DGP, rats in the DGP+IGF-1 group received an intraperitoneal injection of IGF-1 at a dose of 1.5 μg/kg/d for 10 weeks. The level of AMPK activity, liver kinase B1 (LKB1) activity, and calcium/calmodulin-dependent protein kinase b (CaMKKb) expression in rat gastric smooth muscle tissues was detected by Western blot analysis. Apoptosis in rat gastric smooth muscle tissues was detected by TUNEL assay. We also cultured rat GSMCs in vitro under high glucose (HG) condition (35 mM), incubated cells with IGF-1, and silenced AMPK with siRNA. The cells were divided into HG, HG + IGF-1, HG + siRNA, and HG + siRNA + IGF-1 groups. The apoptosis rates of rat GSMCs after silencing AMPK were detected by TUNEL assay and flow cytometry, and apoptosis-related protein expression in rat GSMCs was detected by Western blot.

Results. IGF-1 decreased LKB1 activity, CaMKKb expression, AMPK activity, and inhibited apoptosis in rat gastric smooth muscle tissues. Compared with rat GSMCs cultured in vitro under HG conditions, apoptosis rates were reduced after treatment with IGF-1 and AMPK silencing (both p < 0.01). Apoptosis rates were higher in the HG + siRNA group compared with the HG + IGF-1 group (p < 0.05). IGF-1 down-regulated the expression of calcium/calmodulin-dependent kinase II (CaMKII) and p53, up-regulated the expression of p21, PLC-b3, PI3K p110 Ser1070, and the activities of Akt, p70S6K, mTORC1, and mTORC2. IGF-1 also up-regulated Bcl-2 expression and down-regulated the expression of BAX and Caspase-3.

Conclusions. IGF-1 can inhibit the apoptosis of rat GSMCs under high glucose conditions, its mechanism may be related to the regulation of expression and activity of p53, PI3K, TSC-2, Akt, mTOR, 4E-BP1, p70S6K, p21, CaMKII, and PLC-b3 in rat GSMCs acting through AMPK pathway.

Full Text:

View PDF Download PDF file
Get Citation

Keywords

rat; gastric smooth muscle cells; IGF-1; high glucose; apoptosis; AMPK signaling; siRNA

About this article
Title

Insulin-like growth factor-1 inhibits apoptosis of rat gastric smooth muscle cells under high glucose condition via adenosine monophosphate-activated protein kinase (AMPK) pathway

Journal

Folia Histochemica et Cytobiologica

Issue

Vol 60, No 1 (2022)

Article type

Original paper

Pages

74-88

Published online

2022-02-14

Page views

5955

Article views/downloads

718

DOI

10.5603/FHC.a2022.0005

Pubmed

35156189

Bibliographic record

Folia Histochem Cytobiol 2022;60(1):74-88.

Keywords

rat
gastric smooth muscle cells
IGF-1
high glucose
apoptosis
AMPK signaling
siRNA

Authors

Xiang-zi Zhang
Yan Sun
Mo-han Zhang
Zheng Jin

References (51)
  1. Zhao J, Frøkjaer JB, Drewes AM, et al. Upper gastrointestinal sensory-motor dysfunction in diabetes mellitus. World J Gastroenterol. 2006; 12(18): 2846–2857.
    CrossRefPubMed
  2. Ramzan Z, Duffy F, Gomez J, et al. Continuous glucose monitoring in gastroparesis. Dig Dis Sci. 2011; 56(9): 2646–2655.
    CrossRefPubMed
  3. Hrdinka M, Yabal M. Inhibitor of apoptosis proteins in human health and disease. Genes Immun. 2019; 20(8): 641–650.
    CrossRefPubMed
  4. Zhang MH, Fang XS, Guo JY, et al. Effects of AMPK on Apoptosis and Energy Metabolism of Gastric Smooth Muscle Cells in Rats with Diabetic Gastroparesis. Cell Biochem Biophys. 2019; 77(2): 165–177.
    CrossRefPubMed
  5. Pang L, Yang K, Zhang Z. High-glucose environment accelerates annulus fibrosus cell apoptosis by regulating endoplasmic reticulum stress. Biosci Rep. 2020; 40(7).
    CrossRefPubMed
  6. Yang M, Lin Y, Wang Y, et al. High-glucose induces cardiac myocytes apoptosis through Foxo1 /GRK2 signaling pathway. Biochem Biophys Res Commun. 2019; 513(1): 154–158.
    CrossRefPubMed
  7. Meng S, Cao J, He Q, et al. Metformin activates AMP-activated protein kinase by promoting formation of the αβγ heterotrimeric complex. J Biol Chem. 2015; 290(6): 3793–3802.
    CrossRefPubMed
  8. Nambam B, Schatz D. Growth hormone and insulin-like growth factor-I axis in type 1 diabetes. Growth Horm IGF Res. 2018; 38: 49–52.
    CrossRefPubMed
  9. Li H, Kong R, Wan B, et al. Initiation of PI3K/AKT pathway by IGF-1 decreases spinal cord injury-induced endothelial apoptosis and microvascular damage. Life Sci. 2020; 263: 118572.
    CrossRefPubMed
  10. Luo Li, Lu AM, Wang Y, et al. Chronic resistance training activates autophagy and reduces apoptosis of muscle cells by modulating IGF-1 and its receptors, Akt/mTOR and Akt/FOXO3a signaling in aged rats. Exp Gerontol. 2013; 48(4): 427–436.
    CrossRefPubMed
  11. Vanamala J, Reddivari L, Radhakrishnan S, et al. Resveratrol suppresses IGF-1 induced human colon cancer cell proliferation and elevates apoptosis via suppression of IGF-1R/Wnt and activation of p53 signaling pathways. BMC Cancer. 2010; 10: 238.
    CrossRefPubMed
  12. Zhang MH, Jiang JZ, Cai YL, et al. Significance of dynamic changes in gastric smooth muscle cell apoptosis, PI3K-AKT-mTOR and AMPK-mTOR signaling in a rat model of diabetic gastroparesis. Mol Med Rep. 2017; 16(2): 1530–1536.
    CrossRefPubMed
  13. Fang XS, Zhang MH, Zhang XZ, et al. Insulin-like growth factor-1 inhibits the apoptosis of rat gastric smooth muscle cells cultured under high glucose condition through PI3K-Akt-PKC-Ca2+ pathway. Biotechnology & Biotechnological Equipment. 2019; 33(1): 456–464.
    CrossRef
  14. Miricescu D, Totan A, Stanescu-Spinu II, et al. PI3K/AKT/mTOR Signaling Pathway in Breast Cancer: From Molecular Landscape to Clinical Aspects. Int J Mol Sci. 2020; 22(1).
    CrossRefPubMed
  15. Martini M, De Santis MC, Braccini L, et al. PI3K/AKT signaling pathway and cancer: an updated review. Ann Med. 2014; 46(6): 372–383.
    CrossRefPubMed
  16. Yan J, Wang C, Jin Y, et al. Catalpol ameliorates hepatic insulin resistance in type 2 diabetes through acting on AMPK/NOX4/PI3K/AKT pathway. Pharmacol Res. 2018; 130: 466–480.
    CrossRefPubMed
  17. Liu Y, Deng J, Fan D. Ginsenoside Rk3 ameliorates high-fat-diet/streptozocin induced type 2 diabetes mellitus in mice via the AMPK/Akt signaling pathway. Food Funct. 2019; 10(5): 2538–2551.
    CrossRefPubMed
  18. Ersahin T, Tuncbag N, Cetin-Atalay R. The PI3K/AKT/mTOR interactive pathway. Mol Biosyst. 2015; 11(7): 1946–1954.
    CrossRefPubMed
  19. Shariati M, Meric-Bernstam F. Targeting AKT for cancer therapy. Expert Opin Investig Drugs. 2019; 28(11): 977–988.
    CrossRefPubMed
  20. Yin H, Zhao L, Li S, et al. Impaired Cellular Energy Metabolism Contributes to Duck-Enteritis-Virus-Induced Autophagy via the AMPK-TSC2-MTOR Signaling Pathway. Front Cell Infect Microbiol. 2017; 7: 423.
    CrossRefPubMed
  21. McCampbell AS, Mittelstadt ML, Dere R, et al. Loss of p27 Associated with Risk for Endometrial Carcinoma Arising in the Setting of Obesity. Curr Mol Med. 2016; 16(3): 252–265.
    CrossRefPubMed
  22. Bonucci M, Kuperwasser N, Barbe S, et al. mTOR and S6K1 drive polycystic kidney by the control of Afadin-dependent oriented cell division. Nat Commun. 2020; 11(1): 3200.
    CrossRefPubMed
  23. Rozas NS, Redell JB, Hill JL, et al. Genetic activation of mTORC1 signaling worsens neurocognitive outcome after traumatic brain injury. J Neurotrauma. 2015; 32(2): 149–158.
    CrossRefPubMed
  24. Al-Attar R, Childers CL, Nguyen VuC, et al. Differential protein phosphorylation is responsible for hypoxia-induced regulation of the Akt/mTOR pathway in naked mole rats. Comp Biochem Physiol A Mol Integr Physiol. 2020; 242: 110653.
    CrossRefPubMed
  25. Al Dera H, Eleawa SM, Al-Hashem FH, et al. Enhanced hepatic insulin signaling in the livers of high altitude native rats under basal conditions and in the livers of low altitude native rats under insulin stimulation: a mechanistic study. Arch Physiol Biochem. 2017; 123(3): 145–158.
    CrossRefPubMed
  26. Saxton RA, Sabatini DM. mTOR Signaling in Growth, Metabolism, and Disease. Cell. 2017; 168(6): 960–976.
    CrossRefPubMed
  27. Sangaunchom P, Dharmasaroja P. Caffeine Potentiates Ethanol-Induced Neurotoxicity Through mTOR/p70S6K/4E-BP1 Inhibition in SH-SY5Y Cells. Int J Toxicol. 2020; 39(2): 131–140.
    CrossRefPubMed
  28. Mukaida S, Evans BA, Bengtsson T, et al. Adrenoceptors promote glucose uptake into adipocytes and muscle by an insulin-independent signaling pathway involving mechanistic target of rapamycin complex 2. Pharmacol Res. 2017; 116: 87–92.
    CrossRefPubMed
  29. Sutton LP, Caron MG. Essential role of D1R in the regulation of mTOR complex1 signaling induced by cocaine. Neuropharmacology. 2015; 99: 610–619.
    CrossRefPubMed
  30. Zhang XH, Chen SY, Tang L, et al. Myricetin induces apoptosis in HepG2 cells through Akt/p70S6K/bad signaling and mitochondrial apoptotic pathway. Anticancer Agents Med Chem. 2013; 13(10): 1575–1581.
    CrossRefPubMed
  31. Ragan TJ, Ross DB, Keshwani MM, et al. Expression, purification, and characterization of a structurally disordered and functional C-terminal autoinhibitory domain (AID) of the 70 kDa 40S ribosomal protein S6 kinase-1 (S6K1). Protein Expr Purif. 2008; 57(2): 271–279.
    CrossRefPubMed
  32. Keshwani MM, von Daake S, Newton AC, et al. Hydrophobic motif phosphorylation is not required for activation loop phosphorylation of p70 ribosomal protein S6 kinase 1 (S6K1). J Biol Chem. 2011; 286(26): 23552–23558.
    CrossRefPubMed
  33. Magnuson B, Ekim B, Fingar DC. Regulation and function of ribosomal protein S6 kinase (S6K) within mTOR signalling networks. Biochem J. 2012; 441(1): 1–21.
    CrossRefPubMed
  34. Cheng CY, Kao ST, Lee YC. Ferulic acid ameliorates cerebral infarction by activating Akt/mTOR/4E‑BP1/Bcl‑2 anti‑apoptotic signaling in the penumbral cortex following permanent cerebral ischemia in rats. Mol Med Rep. 2019; 19(2): 792–804.
    CrossRefPubMed
  35. Cheng CY, Kao ST, Lee YC. Ferulic acid ameliorates cerebral infarction by activating Akt/mTOR/4E‑BP1/Bcl‑2 anti‑apoptotic signaling in the penumbral cortex following permanent cerebral ischemia in rats. Mol Med Rep. 2019; 19(2): 792–804.
    CrossRefPubMed
  36. Qin X, Jiang B, Zhang Y. 4E-BP1, a multifactor regulated multifunctional protein. Cell Cycle. 2016; 15(6): 781–786.
    CrossRefPubMed
  37. So L, Lee J, Palafox M, et al. The 4E-BP-eIF4E axis promotes rapamycin-sensitive growth and proliferation in lymphocytes. Sci Signal. 2016; 9(430): ra57.
    CrossRefPubMed
  38. Lieschke E, Wang Z, Kelly GL, et al. Discussion of some 'knowns' and some 'unknowns' about the tumour suppressor p53. J Mol Cell Biol. 2019; 11(3): 212–223.
    CrossRefPubMed
  39. Liu Y, Tavana O, Gu W. p53 modifications: exquisite decorations of the powerful guardian. J Mol Cell Biol. 2019; 11(7): 564–577.
    CrossRefPubMed
  40. Karimian A, Ahmadi Y, Yousefi B. Multiple functions of p21 in cell cycle, apoptosis and transcriptional regulation after DNA damage. DNA Repair (Amst). 2016; 42: 63–71.
    CrossRefPubMed
  41. Yu D, Liu Q, Qiao Bo, et al. Exposure to acrylamide inhibits uterine decidualization via suppression of cyclin D3/p21 and apoptosis in mice. J Hazard Mater. 2020; 388: 121785.
    CrossRefPubMed
  42. Kaluzki I, Hailemariam-Jahn T, Doll M, et al. Dimethylfumarate Inhibits Colorectal Carcinoma Cell Proliferation: Evidence for Cell Cycle Arrest, Apoptosis and Autophagy. Cells. 2019; 8(11).
    CrossRefPubMed
  43. He P, Li Z, Xu F, et al. AMPK Activity Contributes to G2 Arrest and DNA Damage Decrease via p53/p21 Pathways in Oxidatively Damaged Mouse Zygotes. Front Cell Dev Biol. 2020; 8: 539485.
    CrossRefPubMed
  44. Yang D, Zhang Qi, Ma Y, et al. Augmenting the therapeutic efficacy of adenosine against pancreatic cancer by switching the Akt/p21-dependent senescence to apoptosis. EBioMedicine. 2019; 47: 114–127.
    CrossRefPubMed
  45. McConkey D, Orrenius S. The Role of Calcium in the Regulation of Apoptosis. Biochem Biophys Res Commun. 1997; 239(2): 357–366.
    CrossRefPubMed
  46. Finkelstein M, Etkovitz N, Breitbart H. Ca signaling in mammalian spermatozoa. Mol Cell Endocrinol. 2020; 516: 110953.
    CrossRefPubMed
  47. Makhlouf G, Murthy K. Signal Transduction in Gastrointestinal Smooth Muscle. Cell Signal. 1997; 9(3-4): 269–276.
    CrossRef
  48. Nalli AD, Kumar DP, Al-Shboul O, et al. Regulation of Gβγi-dependent PLC-β3 activity in smooth muscle: inhibitory phosphorylation of PLC-β3 by PKA and PKG and stimulatory phosphorylation of Gαi-GTPase-activating protein RGS2 by PKG. Cell Biochem Biophys. 2014; 70(2): 867–880.
    CrossRefPubMed
  49. Simon B, Huart AS, Temmerman K, et al. Molecular mechanisms of protein kinase regulation by calcium/calmodulin. Bioorg Med Chem. 2015; 23(12): 2749–2760.
    CrossRefPubMed
  50. Banerjee C, Khatri P, Raman R, et al. Role of calmodulin-calmodulin kinase II, cAMP/protein kinase A and ERK 1/2 on Aeromonas hydrophila-induced apoptosis of head kidney macrophages. PLoS Pathog. 2014; 10(4): e1004018.
    CrossRefPubMed
  51. Jayanthi LD, Wilson JJ, Montalvo J, et al. Differential regulation of mammalian brain-specific proline transporter by calcium and calcium-dependent protein kinases. Br J Pharmacol. 2000; 129(3): 465–470.
    CrossRefPubMed

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By VM Media Group sp z o.o., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl